[1]
R. Yarema, “Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments”, Curr. Issues Pharm. Med. Sci., vol. 30, no. 4, pp. 190–194, Jan. 2018, doi: 10.1515/cipms-2017-0036.